Omega Fund Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Omega Fund Management’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-560,985	Closed	-$7.85M	–	15
2022 Q4	$7.85M	Hold	560,985	–	–	2.65%	6
2022 Q3	$18.4M	Sell	560,985 -405,191	-42%	-$11.5M	6.74%	4
2022 Q2	$18.2M	Hold	966,176	–	–	5.81%	5
2022 Q1	$16.9M	Buy	+966,176	New	+$19.8M	3.47%	9

Omega Fund Management's CINC Position: Q1 2023 in Review

Omega Fund Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 560,985 shares — an estimated $7.85M sold.

Omega Fund Management first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $18.4M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Omega Fund Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Omega Fund Management sold 560,985 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $7.85M.
Omega Fund Management first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Omega Fund Management's CinCor Pharma, Inc. Common Stock position peaked at $18.4M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Omega Fund Management's 13F filing for Q1 2023, filed 15 May 2023.